During its operations in Q1 2019, the Facility earned revenues of ~$1M.
The facility with 5,000 sq.ft. space, currently produces finished goods products, such as hard and soft-capsules, cartridges, lotions, tinctures, and other liquid formulations, as well as focuses on producing Cannabidiol products.
As deal consideration, Chemesis will issue 0.25M shares at a deemed price of C$2.11.
Subscribe for full text news in your inbox